Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytosolic Delivery of Thiolated Neoantigen Nano‐Vaccine Combined with Immune Checkpoint Blockade to Boost Anti‐Cancer T Cell Immunity
Authors
Keywords
-
Journal
Advanced Science
Volume -, Issue -, Pages 2003504
Publisher
Wiley
Online
2021-01-30
DOI
10.1002/advs.202003504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
- (2020) Geoffrey M. Lynn et al. NATURE BIOTECHNOLOGY
- A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia
- (2020) Nisarg J. Shah et al. Nature Biomedical Engineering
- A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
- (2020) Qianqian Ni et al. Science Advances
- Ultrasound-Driven Biomimetic Nanosystem Suppresses Tumor Growth and Metastasis through Sonodynamic Therapy, CO Therapy, and Indoleamine 2,3-Dioxygenase Inhibition
- (2020) Da Zhang et al. ACS Nano
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Converting Immune Cold into Hot by Biosynthetic Functional Vesicles to Boost Systematic Antitumor Immunity
- (2020) Ming Wu et al. iScience
- Reversing cold tumors to hot: An immunoadjuvant-functionalized metal-organic framework for multimodal imaging-guided synergistic photo-immunotherapy
- (2020) Zhijin Fan et al. Bioactive Materials
- Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity
- (2019) D. Scott Wilson et al. NATURE MATERIALS
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Adding to the checkpoint blockade armamentarium
- (2019) Matthew D. Hellmann et al. NATURE MEDICINE
- Self-Assembled and Size-Controllable Oligonucleotide Nanospheres for Effective Antisense Gene Delivery through an Endocytosis-Independent Pathway
- (2019) Jie Zhou et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators
- (2019) João Conniot et al. Nature Nanotechnology
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- The roles of mesoporous silica and carbon nanoparticles in antigen stability and intensity of immune response against recombinant subunit B of cholera toxin in a rabbit animal model
- (2019) Ali Karimi Bavandpour et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity
- (2019) Hugo G. Hilton et al. PLOS BIOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Cancer immunotherapy making headway
- (2018) Amos Matsiko NATURE MATERIALS
- Update on Tumor Neoantigens and Their Utility: Why It Is Good to Be Different
- (2018) Chung-Han Lee et al. TRENDS IN IMMUNOLOGY
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Programming CAR-T cells to kill cancer
- (2018) Louai Labanieh et al. Nature Biomedical Engineering
- Cancer Neoantigens
- (2018) Ton N. Schumacher et al. Annual Review of Immunology
- The suppressive effect of co-inhibiting PD-1 and CTLA-4 expression on H22 hepatomas in mice
- (2018) Leilei Liang et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Next-generation malarial vaccines
- (2018) Yvette van Kooyk NATURE MATERIALS
- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
- (2017) Yuanzeng Min et al. Nature Nanotechnology
- Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
- (2017) Krzysztof M. Zak et al. STRUCTURE
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Immunogenic peptide discovery in cancer genomes
- (2015) Alexandra Snyder et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Cell-penetrating poly(disulfide)s: the dependence of activity, depolymerization kinetics and intracellular localization on their length
- (2015) Nicolas Chuard et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Peptide/protein vaccine delivery system based on PLGA particles
- (2015) Mojgan Allahyari et al. Human Vaccines & Immunotherapeutics
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More